Ye J - Search Results

1

Triterpene-Based Prodrug for Self-Boosted Drug Release and Targeted Oral Squamous Cell Carcinoma Chemotherapy.

Zhong J, He G, Ma X, Ye J, Tao ZY, Li Z, Zhang F, Feng P, Wang Y, Lan X, Su YX. Zhong J, et al. Among authors: ye j. ACS Appl Mater Interfaces. 2024 Aug 14;16(32):41960-41972. doi: 10.1021/acsami.4c10175. Epub 2024 Jul 31. ACS Appl Mater Interfaces. 2024. PMID: 39082953

2

Exosomes derived from mesenchymal stromal cells promote bone regeneration by delivering miR-182-5p-inhibitor.

Zhu Q, Tang Y, Zhou T, Yang L, Zhang G, Meng Y, Zhang H, Gao J, Wang C, Su YX, Ye J. Zhu Q, et al. Among authors: ye j. Pharmacol Res. 2023 Jun;192:106798. doi: 10.1016/j.phrs.2023.106798. Epub 2023 May 19. Pharmacol Res. 2023. PMID: 37211240 Free article.

3

MiR-200b-5p inhibits tumor progression in salivary adenoid cystic carcinoma via targeting BTBD1.

Tang Y, Zhu Q, Yang L, Meng Y, Zhang G, Zhou T, Wang C, Song X, Su YX, Ye J. Tang Y, et al. Among authors: ye j. Cell Signal. 2023 Sep;109:110748. doi: 10.1016/j.cellsig.2023.110748. Epub 2023 Jun 7. Cell Signal. 2023. PMID: 37290676

4

SATB2 overexpression promotes oral squamous cell carcinoma progression by up-regulating NOX4.

Gao J, Meng Y, Ge X, Hou CX, Zhu QH, Wang YZ, Sun LF, Wang CX, Li HQ, Zhang T, Ye JH. Gao J, et al. Among authors: ye jh. Cell Signal. 2021 Jun;82:109968. doi: 10.1016/j.cellsig.2021.109968. Epub 2021 Mar 3. Cell Signal. 2021. PMID: 33675939

5

Ubiquitin D Promotes Progression of Oral Squamous Cell Carcinoma via NF-Kappa B Signaling.

Song A, Wang Y, Jiang F, Yan E, Zhou J, Ye J, Zhang H, Ding X, Li G, Wu Y, Zheng Y, Song X. Song A, et al. Among authors: ye j. Mol Cells. 2021 Jul 31;44(7):468-480. doi: 10.14348/molcells.2021.2229. Mol Cells. 2021. PMID: 34230226 Free PMC article.

6

Identification of Biomarkers Related to Regulatory T Cell Infiltration in Oral Squamous Cell Carcinoma Based on Integrated Bioinformatics Analysis.

Wang C, Chen Z, Yang X, Zhang W, Zhou J, Zhang H, Ding X, Ye J, Wu H, Wu Y, Zheng Y, Song X. Wang C, et al. Among authors: ye j. Int J Gen Med. 2022 Mar 2;15:2361-2376. doi: 10.2147/IJGM.S349379. eCollection 2022. Int J Gen Med. 2022. PMID: 35264874 Free PMC article.

7

In vitro experimental study on the formation of microRNA-34a loaded exosomes and their inhibitory effect in oral squamous cell carcinoma.

Deng W, Meng Y, Wang B, Wang CX, Hou CX, Zhu QH, Tang YT, Ye JH. Deng W, et al. Cell Cycle. 2022 Aug;21(16):1775-1783. doi: 10.1080/15384101.2022.2070832. Epub 2022 Apr 29. Cell Cycle. 2022. PMID: 35485349 Free PMC article.

8

Characterization of the m⁶A regulator-mediated methylation modification patterns in oral squamous cell carcinoma.

Pan L, She H, Wang K, Xia W, Tang H, Fan Y, Ye J. Pan L, et al. Among authors: ye j. Sci Rep. 2023 Apr 24;13(1):6617. doi: 10.1038/s41598-023-33891-9. Sci Rep. 2023. PMID: 37095314 Free PMC article.

9

circFNDC3B Accelerates Vasculature Formation and Metastasis in Oral Squamous Cell Carcinoma.

Li X, Wang C, Zhang H, Li Y, Hou D, Liu D, Xu R, Cheng J, Liu L, Fu Y, Ye J, Jiang H. Li X, et al. Among authors: ye j. Cancer Res. 2023 May 2;83(9):1459-1475. doi: 10.1158/0008-5472.CAN-22-2585. Cancer Res. 2023. PMID: 36811957 Free PMC article.

10

Overexpression of Hippo pathway effector TAZ in tongue squamous cell carcinoma: correlation with clinicopathological features and patients' prognosis.

Wei Z, Wang Y, Li Z, Yuan C, Zhang W, Wang D, Ye J, Jiang H, Wu Y, Cheng J. Wei Z, et al. Among authors: ye j. J Oral Pathol Med. 2013 Nov;42(10):747-54. doi: 10.1111/jop.12062. Epub 2013 Mar 29. J Oral Pathol Med. 2013. PMID: 23551691

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14,025 results

Search Page

Filters